Cargando…
Development of a New Method for Assessing Global Risk of Alzheimer’s Disease for Use in Population Health Approaches to Prevention
Alzheimer’s disease (AD) affects approximately 35 million people worldwide. Increasing evidence suggests that many risk factors for AD are modifiable. AD pathology develops over decades. Hence risk reduction interventions require very long follow-ups to show effects on AD incidence. Focussing on AD...
Autores principales: | Anstey, Kaarin J., Cherbuin, Nicolas, Herath, Pushpani M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696462/ https://www.ncbi.nlm.nih.gov/pubmed/23319292 http://dx.doi.org/10.1007/s11121-012-0313-2 |
Ejemplares similares
-
A 12-week multidomain intervention versus active control to reduce risk of Alzheimer’s disease: study protocol for a randomized controlled trial
por: Anstey, Kaarin J, et al.
Publicado: (2013) -
The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study
por: Herath, Pushpani M., et al.
Publicado: (2016) -
Body brain life: A randomized controlled trial of an online dementia risk reduction intervention in middle-aged adults at risk of Alzheimer's disease
por: Anstey, Kaarin J., et al.
Publicado: (2015) -
A Self-Report Risk Index to Predict Occurrence of Dementia in Three Independent Cohorts of Older Adults: The ANU-ADRI
por: Anstey, Kaarin J., et al.
Publicado: (2014) -
Assessing reliability of short and tick box forms of the ANU-ADRI: Convenient alternatives of a self-report Alzheimer's disease risk assessment
por: Kim, Sarang, et al.
Publicado: (2016)